259 related articles for article (PubMed ID: 29550515)
1. 15-Deoxy-Δ
Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
[TBL] [Abstract][Full Text] [Related]
3. Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ
Reddy AT; Lakshmi SP; Banno A; Reddy RC
ACS Chem Biol; 2018 Dec; 13(12):3269-3278. PubMed ID: 30398845
[TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-Δ
Kim SJ; Cho NC; Han B; Kim K; Hahn YI; Kim KP; Suh YG; Choi BY; Na HK; Surh YJ
FEBS Lett; 2021 Mar; 595(5):604-622. PubMed ID: 33452674
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ as an electrophilic mediator.
Shibata T
Biosci Biotechnol Biochem; 2015; 79(7):1044-9. PubMed ID: 26011133
[TBL] [Abstract][Full Text] [Related]
6. 15-deoxy-Δ12,14-prostaglandin J₂ induces p53 expression through Nrf2-mediated upregulation of heme oxygenase-1 in human breast cancer cells.
Kim DH; Song NY; Kim EH; Na HK; Joe Y; Chung HT; Surh YJ
Free Radic Res; 2014 Sep; 48(9):1018-27. PubMed ID: 24568186
[TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-Δ
Choi JE; Kim JH; Song NY; Suh J; Kim DH; Kim SJ; Na HK; Nadas J; Dong Z; Cha YN; Surh YJ
Free Radic Res; 2016 Oct; 50(10):1140-1152. PubMed ID: 27598034
[TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS.
Kim EH; Na HK; Kim DH; Park SA; Kim HN; Song NY; Surh YJ
Carcinogenesis; 2008 Apr; 29(4):688-95. PubMed ID: 18192694
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.
Yen CC; Hsiao CD; Chen WM; Wen YS; Lin YC; Chang TW; Yao FY; Hung SC; Wang JY; Chiu JH; Wang HW; Lin CH; Chen TH; Chen PC; Liu CL; Tzeng CH; Fletcher JA
Oncotarget; 2014 Feb; 5(3):716-25. PubMed ID: 24566468
[TBL] [Abstract][Full Text] [Related]
10. Physiological and Pathological Roles of 15-Deoxy-Δ
Yagami T; Yamamoto Y; Koma H
Mol Neurobiol; 2018 Mar; 55(3):2227-2248. PubMed ID: 28299574
[TBL] [Abstract][Full Text] [Related]
11. 15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells.
Kang ES; Hwang JS; Ham SA; Park MH; Kim GH; Paek KS; Yoo T; Lee WJ; Kang KR; Lee JH; Choi YJ; Seo HG
Free Radic Res; 2014 Feb; 48(2):218-29. PubMed ID: 24180671
[TBL] [Abstract][Full Text] [Related]
12. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death.
Koyani CN; Kitz K; Rossmann C; Bernhart E; Huber E; Trummer C; Windischhofer W; Sattler W; Malle E
Biochem Pharmacol; 2016 Mar; 104():29-41. PubMed ID: 26801686
[TBL] [Abstract][Full Text] [Related]
13. 15-Deoxy-Δ
Koma H; Yamamoto Y; Nishii A; Yagami T
Neuropharmacology; 2017 Feb; 113(Pt A):416-425. PubMed ID: 27771378
[TBL] [Abstract][Full Text] [Related]
14. 15-Deoxy-Δ
Na HK; Yang H; Surh YJ
J Cancer Prev; 2020 Jun; 25(2):100-110. PubMed ID: 32647651
[TBL] [Abstract][Full Text] [Related]
15. Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog.
Wall SB; Oh JY; Mitchell L; Laube AH; Campbell SL; Renfrow MB; Landar A
Redox Biol; 2015; 4():346-54. PubMed ID: 25677088
[TBL] [Abstract][Full Text] [Related]
16. 15-Deoxy-Δ
Choi J; Suh JY; Kim DH; Na HK; Surh YJ
J Cancer Prev; 2020 Sep; 25(3):152-163. PubMed ID: 33033709
[TBL] [Abstract][Full Text] [Related]
17. 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS.
Kim DH; Kim JH; Kim EH; Na HK; Cha YN; Chung JH; Surh YJ
Carcinogenesis; 2009 Apr; 30(4):645-54. PubMed ID: 19136476
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue.
Kim DH; Kim EH; Na HK; Sun Y; Surh YJ
Oncogene; 2010 Apr; 29(17):2560-76. PubMed ID: 20208557
[TBL] [Abstract][Full Text] [Related]
19. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
Giri S; Rattan R; Singh AK; Singh I
J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
[TBL] [Abstract][Full Text] [Related]
20. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
Kim DH; Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
